Stock Earnings

Question 1

Editas Medicine Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Editas Medicine Inc의 총 자산은 $341이며, 순loss입니다.

Question 2

EDIT의 주요 재무 비율은 무엇인가요?

Accepted Answer

Editas Medicine Inc의 유동비율은 1.64이고, 순이익률은 -740.62, 주당 매출은 $0.38입니다.

Question 3

Editas Medicine Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Editas Medicine Inc largest revenue segment is Genome Editing Technology, at a revenue of 32,314,000 in the most earnings release.For geography, United States is the primary market for Editas Medicine Inc, at a revenue of 32,314,000.

Question 4

Editas Medicine Inc은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Editas Medicine Inc의 순loss은 $-237입니다.

Question 5

Editas Medicine Inc에 부채가 있나요?

Accepted Answer

yes, Editas Medicine Inc의 부채는 207입니다.

Question 6

Editas Medicine Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Editas Medicine Inc의 총 발행 주식은 82.73주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	46	32	78	19	25	90
Revenue Growth (YoY)	-25%	-59%	311%	-24%	-72%	350%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	54	71	69	70	76	67
Research & Development	111	199	177	174	142	158
Operating Expenses	166	271	247	245	218	225
Other Non Operating Income (Expenses)	-2	0	-1	1	-1	16
Pretax Income	-199	-237	-153	-220	-192	-115
Income Tax Expense	--	0	--	--	--	--
Net Income	-199	-237	-153	-220	-192	-115
Net Income Growth	-5%	55%	-30%	15%	67%	-14%
Shares Outstanding (Diluted)	90.09	82.33	75.96	68.66	67.62	58.61
Shares Change (YoY)	9%	8%	11%	2%	15%	17%
EPS (Diluted)	-2.21	-2.87	-2.01	-3.21	-2.85	-1.98
EPS Growth	-14%	43%	-37%	13%	44%	-26%
Free Cash Flow	-180	-219	-136	-181	-171	-187
Free Cash Flow Per Share	-1.99	-2.65	-1.79	-2.63	-2.52	-3.19
Gross Margin	--	--	--	--	--	--
Operating Margin	-258.69%	-743.75%	-216.66%	-1,184.21%	-772%	-148.88%
Profit Margin	-432.6%	-740.62%	-196.15%	-1,157.89%	-768%	-127.77%
Free Cash Flow Margin	-391.3%	-684.37%	-174.35%	-952.63%	-684%	-207.77%
EBITDA	-114	-233	-163	-219	-188	-131
EBITDA Margin	-247.82%	-728.12%	-208.97%	-1,152.63%	-752%	-145.55%
D&A For EBITDA	5	5	6	6	5	3
EBIT	-119	-238	-169	-225	-193	-134
EBIT Margin	-258.69%	-743.75%	-216.66%	-1,184.21%	-772%	-148.88%
Effective Tax Rate	--	0%	--	--	--	--

Editas Medicine Inc (EDIT) Price

EDIT Stock Price Chart

EDIT Income

Follow-Up Questions